-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 11, Shanghai Pharmaceuticals issued a plan for non-public issuance of A shares
.
According to the plan, Shanghai Pharmaceuticals intends to issue a total of no more than 852,626,796 A shares to Yunnan Baiyao Group Co.
According to the announcement, Yunnan Baiyao has subscribed for a total of 11.
229 billion yuan in this issuance
.
After the issuance is expected, Yunnan Baiyao will hold 18.
Another fixed increase target Shanghai Tandong is a wholly-owned subsidiary of Shanghai Shangshi, which will also invest 3.
155 billion yuan this time
.
After the issuance is completed, Shanghai Industrial Group and its related parties will still serve as the controlling shareholders of Shanghai Pharmaceuticals, holding 33.